The present invention pertains to a therapeutic agent against diseases involving Nav 1.7, specifically, diseases such as neuropathic pain, nociceptive pain, inflammatory pain, small fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, or multiple sclerosis, the therapeutic agent containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof [in the formula, R